Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    225 Ac-Psma-617

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Niowave, Novartis Ink Actinium-225 Deal for Cancer Therapy
    Niowave, Novartis Ink Actinium-225 Deal for Cancer Therapy

    11 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/niowave-and-novartis-enter-global-actinium-225-supply-agreement-to-advance-next-generation-cancer-therapies-302684489.html

    PR NEWSWIRE
    11 Feb 2026
    Share Share
    Novartis Cuts 6 Cancer Candidates, Adds 2 to Oncology Strategy
    Novartis Cuts 6 Cancer Candidates, Adds 2 to Oncology Strategy

    05 Feb 2026

    // BIOSPACE

    https://www.biospace.com/business/novartis-cuts-6-early-cancer-candidates-adds-2-to-refine-oncology-strategy

    BIOSPACE
    05 Feb 2026
    Share Share
    NorthStar Confirms Successful Commercial-Scale Ac-225 Production
    NorthStar Confirms Successful Commercial-Scale Ac-225 Production

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106279631/en/NorthStar-Medical-Radioisotopes-Confirms-Successful-Routine-Commercial-scale-Ac-225-Production

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    AtomVie Secures Ac-225 Supply from Ionetix to Advance Radiopharma
    AtomVie Secures Ac-225 Supply from Ionetix to Advance Radiopharma

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-secures-a-supply-agreement-with-ionetix-corporation-to-accelerate-ac-225-radiotherapeutics-development-302645520.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share
    Niowave Expands Supply Deal With Astrazeneca For Actinium-225
    Niowave Expands Supply Deal With Astrazeneca For Actinium-225

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/niowave-expands-global-supply-agreement-with-astrazeneca-to-deliver-actinium-225-for-next-generation-cancer-therapies-302646279.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share
    Cellectar Bio Inks Actinium-225 Deal With Ionetix
    Cellectar Bio Inks Actinium-225 Deal With Ionetix

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206203/29076/en/Cellectar-Biosciences-Announces-Strategic-Supply-Agreement-with-Ionetix-for-Actinium-225-and-Astatine-211-to-Advance-Targeted-Alpha-Therapies.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.